HomeAI · summaries
Storia in 12 fonti
China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
- ·
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines
- ·
biopharmadive.com
Pfizer, Innovent strike $10B cancer drug deal
Involving up to 12 antibody drugs, the alliance is the latest broad partnership between Chinese biotech and a multinational pharmaceutical company.
- ·
thehindubusinessline.com
Pfizer inks up to $10.5 billion deal with China’s Innovent Biologics
Pfizer Inc. and China’s Innovent Biologics Inc. signed a global agreement worth as much as $10.5 billion to develop cancer drugs.
- ·
asia.nikkei.com
China's Innovent Biologics signs drug deal with Pfizer worth up to $10.5bn
Biotech firm says global expansion still under development
- ·
cnbc.com
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
- ·
scmp.com
China’s Innovent Biologics signs US$10.5b Pfizer deal for 12 cancer drug trials
The agreement covers eight early-stage trials from Innovent and four discovery programmes from global giant Pfizer.
- ·
benzinga.com
Pfizer Strikes Up To $10.5 Billion Deal With Innovent Biologics - Pfizer (NYSE:PFE)
Pfizer and Innovent Biologics sign a $10.5 billion cancer drug deal to develop 12 oncology programs globally.
- ·
pharmaceutical-technology.com
Pfizer, Innovent Biologics sign $10.5bn cancer drug development deal
Pfizer and Innovent Biologics have signed a global licensing and collaboration agreement worth up to $10.5bn for the research and development of a portfolio of 12 early-stage…
- ·
startmag.it
L'accordo con Innovent Biologics fa tenere a Pfizer un piede negli Usa e l'altro in Cina - Startmag
La collaborazione tra Pfizer e Innovent riguarda un portafoglio di 12 programmi oncologici, composto da 8 asset in fase iniziale
- ·
endpoints.news
Pfizer strikes Innovent deal worth up to $10.5B for a dozen cancer programs
On the eve of this year’s ASCO annual meeting, Pfizer said it is teaming up with China’s Innovent Biologics to advance a portfolio of 12 early-stage antibody-drug conjugates and…
- ·
qz.com
Pfizer and Innovent Biologics sign $10.5B cancer drug deal
The U.S. pharma giant will pay $650 million upfront to China's Innovent Biologics to co-develop 12 early-stage oncology programs
- ·
fiercepharma.com
Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
As China-developed assets gain more attention from biopharma dealmakers, some industry watchers want to cur | As China-developed assets gain more attention from biopharma…